Metahexamide
WikiDoc Resources for Metahexamide |
Articles |
---|
Most recent articles on Metahexamide Most cited articles on Metahexamide |
Media |
Powerpoint slides on Metahexamide |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Metahexamide at Clinical Trials.gov Clinical Trials on Metahexamide at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Metahexamide
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Metahexamide Discussion groups on Metahexamide Patient Handouts on Metahexamide Directions to Hospitals Treating Metahexamide Risk calculators and risk factors for Metahexamide
|
Healthcare Provider Resources |
Causes & Risk Factors for Metahexamide |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Metahexamide (INN) is an anti-diabetic drug from the group of sulfonylureas. It was first described in 1959.[1]
References
- ↑ Moss JM, Delawter D (September 1959). "Metahexamide in diabetes therapy". Ann NY Acad Sci. 82 (2): 614–7. doi:10.1111/j.1749-6632.1959.tb44940.x. PMID 14424617.